Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Edison Nation Medical Seeks to Reduce Accidental Drug Poisonings by Launching Innovation Search to Improve Design and Packaging of Medications

Inventors Earn 50 Percent of Licensing Royalties for Successfully Commercialized Ideas


News provided by

Edison Nation Medical

Mar 12, 2014, 09:25 ET

Share this article

Share toX

Share this article

Share toX

CHARLOTTE, N.C., March 12, 2014 /PRNewswire/ -- Edison Nation Medical, a medical device incubator and healthcare innovation portal, is launching a global search to uncover innovative ideas for improving the design, packaging and administration of medications as a way to address the issue of accidental poisonings. This search coincides with National Poison Prevention Week, which takes place March 16 – 22.

Every 15 seconds, a Poison Control Center somewhere in the United States receives a call. According to the Centers for Disease Control and Prevention (CDC), there are approximately 2 million poison exposures in the United States every year—57 percent among children under the age of six.

In 2007, Dr. Daniel Budnitz, a scientist with the CDC's Medication and Safety Program, started tracking children who were treated in emergency rooms after potentially toxic accidental pharmaceutical poisonings. At the conclusion of his tracking period in 2011, federal estimates put the number at around 74,000, which surpassed the number of children younger than six who needed emergency room treatment as a result of car crashes.

Poisoning from medication also affects the elderly; these poisonings are more likely to require hospitalization and to be fatal compared with younger individuals. Analgesics, cardiovascular medications, COPD and asthma preparations, antidepressants and other psychotropic medications are most commonly implicated in drug poisoning fatalities in elderly Americans. The primary reasons for unintentional drug poisonings in older patients include taking more than the prescribed dose, taking someone else's medication, administering medication incorrectly and storing medication improperly. 

According to the CDC, more than 41,000 people died as a result of poisoning in 2008 and more than 76 percent of those poisoning deaths were unintentional.

"The fact that nearly 9 out of 10 poisoning deaths are caused by pharmaceutical medications is alarming," said Julie Wheelan, vice president of marketing for Edison Nation Medical. "There is clearly an urgent need for re-evaluating our current system of packaging and administering medications. While there have been a few innovations to help minimize accidental drug poisonings, I'm confident we can find better solutions."

Innovations designed to protect against accidental drug poisonings include, but may not be limited to, child resistant bottle caps, Clear Rx and flow restrictors, all of which are described below.

Child Resistant Caps
The first flavored children's aspirin was produced in the 1940s as a way to make medicine more pleasing to children. The unexpected consequence of this, however, was that children were more likely to seek—and take—the medicine with no adult supervision, almost as if it were candy. During the 1940s and 1950s, aspirin poisoning constituted 25 percent of all poisonings in children. At that time, Dr. Jay Arena, a pediatrician at Duke University, led the push for drug companies to develop a childproof safety cap. While the cap has helped minimize poisonings since its inception, it is child-resistant, not child-proof.

Clear Rx
Many years later, graduate student Deborah Adler embarked on a school project to address the shortcomings of the standard round plastic pill bottles. In early 2000, she began working on "Safe Rx" by identifying the problems with traditional pill bottles, including inconsistent labeling, round shape that can render instructions difficult to read, confusing numbers and date information, oversized pharmacy logos that crowd out pertinent information, and poorly designed color combinations for warning labels. The resulting product was a more intuitive pill bottle with an easy-to-read label, removable information card, color-coded rings that can be assigned to each person in a household and redesigned warning icons. Adler approached pharmaceutical retailers and the FDA, but Target Corporation ultimately patented and retained exclusive rights to the system, now known as "Clear Rx." Target rolled out the new system in 2005.

Flow Restrictors
In 2007, the aforementioned Dr. Budnitz worked to try to reduce the growing numbers of children who were accidentally poisoned by pharmaceuticals. He persuaded drug makers, federal regulators and poison experts to come together on an initiative to add flow restrictors to medicine bottles, which could serve as a backup if children successfully opened a medication's safety cap or if caregivers left medicine bottles open and unattended. These flow restrictors have not been widely adopted.

"Pharmaceutical poisonings are heartbreaking since these accidents are almost 100% preventable," stated Bobby Grajewski, president of Edison Nation Medical. "We are confident that bright ideas exist in the minds of patients, physicians, nurses and others for improving the manner in which medications are designed, packaged and administered to better protect children, the elderly and, really, anyone who has exposure to pharmaceuticals. We are eager to receive these ideas and help bring them to life in order to eliminate these senseless accidents and deaths."

Edison Nation Medical provides a clear pathway for anyone with a new medical invention idea—doctors, nurses, technicians, patients, caregivers and entrepreneurs—to get their idea to market by breaking down the traditional barriers to entry, which include time, money, expertise and access. 

Anyone with a relevant search idea may submit it to the confidential portal at http://EdisonNationMedical.com/PoisonControl through May 5. The best ideas will be designed, developed and licensed by Edison Nation Medical, which then splits licensing royalties 50/50 with successful inventors.

Individuals pay a $25 submission fee for each idea. There is no limit to the number of ideas an inventor may submit. Edison Nation Medical absorbs all subsequent research, patent and development costs.

ABOUT EDISON NATION MEDICAL

Edison Nation Medical is a medical device incubator and health care innovation portal with deep product development and medical expertise. A collaboration between Carolinas HealthCare System, one of the nation's leading health care systems, and Edison Nation, prolific product developer and online social community for inventors, Edison Nation Medical's mission is to create more effective, efficient and safer health care through innovation by breaking down traditional barriers and providing an easy way for new medical product inventions to come to life.

Edison Nation Medical is based in Charlotte, N.C. For more information on the company, please visit www.EdisonNationMedical.com. 

SOURCE Edison Nation Medical

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.